Daynna Wolff to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications Daynna Wolff has written about In Situ Hybridization, Fluorescence.
Connection Strength
1.986
-
Guidance for fluorescence in situ hybridization testing in hematologic disorders. J Mol Diagn. 2007 Apr; 9(2):134-43.
Score: 0.280
-
Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int. 2005 Dec; 96(9):1280-5.
Score: 0.255
-
Novel high-risk acute myeloid leukemia subgroup with ERG amplification and Biallelic loss of TP53. Cancer Genet. 2023 04; 272-273:23-28.
Score: 0.209
-
Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia. Cancer Genet. 2020 08; 246-247:44-47.
Score: 0.177
-
A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays. Cancer Genet. 2015 Nov; 208(11):525-36.
Score: 0.125
-
Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation. Cancer Cytopathol. 2013 Oct; 121(10):591-7.
Score: 0.108
-
Association of age with fluorescence in situ hybridization abnormalities in multiple myeloma reveals higher rate of IGH translocations among older patients. Leuk Lymphoma. 2012 Dec; 53(12):2444-8.
Score: 0.100
-
Validation of fluorescence in situ hybridization using an analyte-specific reagent for detection of abnormalities involving the mixed lineage leukemia gene. Arch Pathol Lab Med. 2012 Jan; 136(1):47-52.
Score: 0.097
-
Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia. Cancer Genet. 2011 Dec; 204(12):654-65.
Score: 0.097
-
The utility of fluorescence in situ hybridization (FISH) analysis in diagnosing graft versus host disease following orthotopic liver transplant. Ann Clin Lab Sci. 2011; 41(2):188-92.
Score: 0.091
-
HER2 testing: a review of detection methodologies and their clinical performance. Expert Rev Mol Diagn. 2007 Jan; 7(1):53-64.
Score: 0.069
-
The genetics of bladder cancer: a cytogeneticist's perspective. Cytogenet Genome Res. 2007; 118(2-4):177-81.
Score: 0.069
-
Pediatric T-cell acute lymphoblastic leukemia with aberrations of both MLL loci. Cancer Genet Cytogenet. 2006 Jul 01; 168(1):77-9.
Score: 0.066
-
Abnormal fluorescence in situ hybridization analysis in collecting duct carcinoma. Urology. 2005 Nov; 66(5):1110.
Score: 0.064
-
A case of infantile acute myelogenous leukemia with MLL-MLL10 fusion caused by insertion of 11q into 10p. Cancer Genet Cytogenet. 2005 Jun; 159(2):181-3.
Score: 0.062
-
Urothelial carcinoma of donor origin in a kidney transplant patient. J Immunother Cancer. 2016; 4:63.
Score: 0.034
-
Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases. Turk Patoloji Derg. 2016; 32(3):178-85.
Score: 0.032
-
"Low-Fat" Pseudoangiomatous Spindle Cell Lipoma: A Rare Variant With Loss of 13q14 Region. Am J Dermatopathol. 2015 Dec; 37(12):920-3.
Score: 0.032
-
Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report. Cancer Genet Cytogenet. 2008 May; 183(1):64-8.
Score: 0.019